- AUPH -0.17%
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Yahoo Finance · 2 weeks ago
Search results
- 5.76Add to watchlist-0.01 (-0.17%)At close:4:00 PM EDTFri. May 17, 20245.78 +0.02 (+0.35%)After hrs:5:43 PM EDTFri. May 17, 2024Nasdaq Real Time Price (USD) · Market closed
- Open5.80High5.83Low5.65
- Mkt Cap823.79MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close5.7752 Wk. Low4.7152 Wk. High12.43
Top storiesRelated stocks
At Aurinia, we embrace the possibility to change the trajectory of autoimmune diseases with unmet needs. With a growing pipeline and a dynamic team of proven experts, our work is patient-centric and driven by a sense of urgency. See how we are poised to deliver on our mission. Learn More.
- Company Information
Company Contact Aurinia Pharmaceuticals Inc. #140, 14315 –...
- Management Team
ABOUT US. The Aurinia logo is a modern representation of the...
- Our Science
Our development of LUPKYNIS ® (voclosporin) to treat active...
- Investors & Media
Company Overview. Aurinia Pharmaceuticals is a fully...
- Aurinia in Action
Despite the high incidence of lupus nephritis among people...
- Press Releases
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial...
- News & Events
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial...
- Company Information
Find the latest Aurinia Pharmaceuticals Inc. (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
Get the latest Aurinia Pharmaceuticals Inc (AUPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Nov 2, 2023 · AURINIA PHARMACEUTICALS INC. AND SUBSIDIARIES. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) September 30, 2023. December 31, 2022. ASSETS. Current assets.
